发明授权
- 专利标题： SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
- 专利标题（中）： 取代OXOAZAHETEROCYCLYL Xa因子抑制剂
-
申请号： EP99906684.8申请日： 1999-01-27
-
公开(公告)号： EP1051176B1公开(公告)日： 2006-11-22
- 发明人: EWING, William, R. , BECKER, Michael, R. , CHOI-SLEDESKI, Yong, Mi , PAULS, Heinz, W. , HE, Wei , CONDON, Stephen, M. , DAVIS, Roderick, S. , HANNEY, Barbara, A. , SPADA, Alfred, P. , BURNS, Christopher, J. , JIANG, John, Z. , LI, Aiwen , MYERS, Michael, R. , LAU, Wan, F. , POLI, Gregory, B.
- 申请人： Aventis Pharmaceuticals, Inc.
- 申请人地址： 300 Somerset Corporate Boulevard Bridgewater, New Jersey 08807 US
- 专利权人： Aventis Pharmaceuticals, Inc.
- 当前专利权人： Aventis Pharmaceuticals, Inc.
- 当前专利权人地址： 300 Somerset Corporate Boulevard Bridgewater, New Jersey 08807 US
- 代理机构： Then, Johann
- 优先权： US72707P 19980127
- 国际公布： WO1999037304 19990729
- 主分类号： C07D241/08
- IPC分类号： C07D241/08 ; A61K31/495
摘要：
This invention is directed to oxoazaheterocyclyl compounds which inhibit factor Xa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds and to a method of inhibiting factor Xa.
公开/授权文献
- EP1051176A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS 公开/授权日：2000-11-15
信息查询
